Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Subscribe biotechnology, chronic disease, CMS, Donald Trump, Drug prices, Medicaid, Medicare, Medicare negotiation, Obesity, Pharmaceuticals, Policy, STAT+ Daniel covers the intersection of the health industry and the federal government
March 26 Product: Mercks Winrevair Indication: Pulmonary arterial hypertension People with pulmonary arterial hypertension (PAH) now have a therapy that targets the root of their disease after the FDA approved Mercks Winrevair on Tuesday
Abuse is the intentional non-therapeutic use of a drug, even once, to achieve a desired psychological or physiological effect
Andrew Huberman: I will say I pull a few all-nighters per year just for work demands and procrastination and deadlines
US$ 23.28
US$ 27.03
US$ 21.01
US$ 27.07
US$ 28.21
US$ 22.30
